|
|
Volumn , Issue 41, 1994, Pages 339-347
|
|
Biochemical pharmacology of befloxatone (MD370503), a new potent reversible MAO-A inhibitor
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A;
ANTIDEPRESSANT AGENT;
BEFLOXATONE;
MONOAMINE OXIDASE INHIBITOR;
PHENELZINE;
TYRAMINE;
AMINE OXIDASE (FLAVIN CONTAINING);
OXAZOLE DERIVATIVE;
ANIMAL EXPERIMENT;
ANIMAL TISSUE;
BEHAVIOR;
CONFERENCE PAPER;
CONTROLLED STUDY;
ENZYME ACTIVITY;
HUMAN;
HUMAN TISSUE;
MOUSE;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
RAT;
ANIMAL;
ANIMAL BEHAVIOR;
ARTICLE;
BRAIN;
CHEMISTRY;
DRUG EFFECT;
DRUG INTERACTION;
IN VITRO STUDY;
MALE;
METABOLISM;
MOUSE STRAIN;
RAT STRAIN;
ANIMAL;
ANTIDEPRESSIVE AGENTS;
BEHAVIOR, ANIMAL;
BRAIN;
DRUG INTERACTIONS;
HUMAN;
IN VITRO;
MALE;
MICE;
MICE, INBRED STRAINS;
MONOAMINE OXIDASE;
MONOAMINE OXIDASE INHIBITORS;
OXAZOLES;
RATS;
RATS, SPRAGUE-DAWLEY;
TYRAMINE;
|
|
EID: 0028182796
PISSN: 03036995
EISSN: None
Source Type: Book Series
DOI: 10.1007/978-3-7091-9324-2_45 Document Type: Conference Paper |
|
Times cited : (21)
|
|
References (0)
|
